Antagonism by theophylline of respiratory inhibition induced by adenosine.
The effects on respiration of an analogue of adenosine, L-2-N6-(phenylisopropyl)adenosine (PIA), and of the methylxanthine, theophylline, were determined in 19 vagotomized glomectomized cats whose end-tidal PCO2 was kept constant by means of a servo-controlled ventilator. Integrated phrenic nerve activity was used to represent respiratory output. Our results show that PIA, whether given systemically or into the third cerebral ventricle, depressed respiration. Systemically administered theophylline stimulated respiration. Theophylline given intravenously, or into the third ventricle not only reversed the depressive effects of previously administered PIA but caused further increases of respiration above the control level. Prior systemic administration of theophylline blocked both respiratory and hypotensive effects of subsequently administered PIA. Effects of either agent on medullary extracellular fluid pH did not explain the results. We conclude that the adenosine analogue PIA, acts to inhibit neurons in the brain that are involved in the control of respiration and that its effects are blocked by theophylline. We suggest that adenosine acts as a tonic modulator of respiration and that theophylline stimulates breathing by competitive antagonism of adenosine at neuronal receptor sites.
D000241:Adenosine / Q000031:analogs & derivatives*; D000818:Animals; D002415:Cats; D007275:Injections, Intravenous; D007276:Injections, Intraventricular; D010660:Phenylisopropyladenosine / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D010791:Phrenic Nerve / Q000187:drug effects / Q000502:physiology; D012119:Respiration / Q000187:drug effects*; D013806:Theophylline / Q000008:administration & dosage / Q000494:pharmacology*
D010660:Phenylisopropyladenosine; D013806:Theophylline; D000241:Adenosine